Emerging synthetic biology strategies such as CCR10 knock-down or overexpression, or engineering CAR T cells with CCR10-based trafficking modules offer innovative avenues to modulate immune responses and restrict tumor spread. This evidence concerns the gene CCR10 and neoplasm.